Overview

A Long-term Safety Study of QMF149 in Japanese Participants With Asthma

Status:
Completed
Trial end date:
2019-02-12
Target enrollment:
Participant gender:
Summary
The purpose of this study was to provide long term safety data of QMF149 in Japanese participants with inadequately controlled asthma for the registration of QMF149 in Japan.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals